Evidence map›Paper›PMID 34461911›Full record

ArticleMalaria journal2021

Transfluthrin eave-positioned targeted insecticide (EPTI) reduces human landing rate (HLR) of pyrethroid resistant and susceptible malaria vectors in a semi-field simulated peridomestic space.

Mgeni M Tambwe, Sarah Moore, Lorenz Hofer, Ummi A Kibondo, Adam Saddler

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. The BiteBarrier perimeter: A passive spatial device for tick control and bite prevention.Current research in parasitology & vector-borne diseases · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Mgeni M TambweVector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania. mmohamed@ihi.or.tz.
Sarah MooreVector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Lorenz HoferVector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Ummi A KibondoVector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Adam SaddlerVector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Ifakara Health Institute · TZUniversity of Basel · CHThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVolatile pyrethroids (VPs) are proven to reduce human-vector contact for mosquito vectors. With increasing resistance to pyrethroids in mosquitoes, the efficacy of VPs, such as transfluthrin, may be compromised. Therefore, experiments were conducted to determine if the efficacy of transfluthrin eave-positioned targeted insecticide (EPTI) depends on the resistance status of malaria vectors.

methodsRibbons treated with 5.25 g transfluthrin or untreated controls were used around the eaves of an experimental hut as EPTI inside a semi-field system. Mosquito strains with different levels of pyrethroid resistance were released simultaneously, recaptured by means of human landing catches (HLCs) and monitored for 24-h mortality. Technical-grade (TG) transfluthrin was used, followed by emulsifiable concentrate (EC) transfluthrin and additional mosquito strains. Generalized linear mixed models with binomial distribution were used to determine the impact of transfluthrin and mosquito strain on mosquito landing rates and 24-h mortality.

resultsEPTI treated with 5.25 g of either TG or EC transfluthrin significantly reduced HLR of all susceptible and resistant Anopheles mosquitoes (Odds Ratio (OR) ranging from 0.14 (95% Confidence Interval (CI) [0.11-0.17], P < 0.001) to 0.57, (CI [0.42-0.78] P < 0.001). Both TG and EC EPTI had less impact on landing for the resistant Anopheles arabiensis (Mbita strain) compared to the susceptible Anopheles gambiae (Ifakara strain) (OR 1.50 [95% CI 1.18-1.91] P < 0.001) and (OR 1.67 [95% CI 1.29-2.17] P < 0.001), respectively. The EC EPTI also had less impact on the resistant An. arabiensis (Kingani strain) (OR 2.29 [95% CI 1.78-2.94] P < 0.001) compared to the control however the TG EPTI was equally effective against the resistant Kingani strain and susceptible Ifakara strain (OR 1.03 [95% CI 0.82-1.32] P = 0.75). Finally the EC EPTI was equally effective against the susceptible An. gambiae (Kisumu strain) and the resistant An. gambiae (Kisumu-kdr strain) (OR 0.98 [95% CI 0.74-1.30] P = 0.90).

conclusionsTransfluthrin-treated EPTI could be useful in areas with pyrethroid-resistant mosquitoes, but it remains unclear whether stronger resistance to pyrethroids will undermine the efficacy of transfluthrin. At this dosage, transfluthrin EPTI cannot be used to kill exposed mosquitoes.

Indexed as

AnophelesCyclopropanesFluorobenzenesInsecticide ResistanceInsect RepellentsMosquito VectorsPyrethrinsAnimalsFemaleHousingInsect Bites and StingsMalariaMosquito ControlCyclopropanesFluorobenzenesInsect RepellentsPyrethrinstransfluthrinAnopheles arabiensisAnopheles gambiaeEave-positioned targeted insecticideEPTIPyrethroid resistanceSemi-field systemTransfluthrinVolatile pyrethroid

Identifiers

PMID34461911
PMCPMC8404287
OpenAlexW3137503798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.